Question explored with the scientific record
Conversation so far
- …started from a private conversation
- 1 Did Gates’s foundation or companies earn royalties from COVID vaccines?
- 2 If no royalties exist, what evidence supports or refutes the Gates profit claims?
Answered on this page ↓
If no royalties exist, what evidence supports or refutes the Gates profit claims?
The evidence block contains nothing about Gates foundation royalties from COVID vaccines. You already got that answer, and it has not changed.
The retrieved records are on vaccine potency assays [1], modeling methods [1, 4], and financial reporting in Indonesian charities [20] and Ukrainian companies [10]. None of them name Bill Gates, his foundation, any royalty payment, or any licensing agreement tied to COVID-19 vaccines. The same hole from the previous question is still there.
Public financial disclosures and IRS Form 990 filings for the Gates Foundation exist in the real world, and the foundation publishes audited financial statements annually. But those documents are not in this evidence block. Without a record that names specific licensing terms, equity stakes, or royalty streams from COVID-19 vaccine manufacturers, any answer would be speculation.
My call: the evidence still does not reach the question. Confidence: not clear — the answer is almost certainly knowable from external documents, but this retrieval does not contain them.
Sources examined 20
-
How can the public health impact of vaccination be estimated?
This paper describes and evaluates a suite of methods used by the Vaccine Impact Modelling Consortium (VIMC) to estimate the public health impact of vaccination, including calendar year, birth year, year-of-vaccination (YoV) methods and an impact extrapolation (IE) approach, dem…
DOI: 10.1186/s12889-021-12040-9 -
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies
A perspective on developing functionally relevant potency assays for monovalent and multivalent vaccines across evolving technologies, emphasizing the need for selective antibodies, in vitro–in vivo correlations, and global analytical capabilities across platforms including mRNA…
DOI: 10.1038/s41541-022-00470-4 -
Multivalent Rotavirus Vaccine and Wild-type Rotavirus Strain Shedding in Australian Infants: A Birth Cohort Study
This study investigates the prevalence and duration of rotavirus vaccine shedding in a community-based birth cohort of Australian infants, finding that a significant proportion shed the vaccine strain post-vaccination, with implications for interpreting diagnostic tests and moni…
DOI: 10.1093/cid/cix1022 -
Primary healthcare system performance in low-income and middle-income countries: a scoping review of the evidence from 2010 to 2017
A scoping review of primary healthcare in low- and middle-income countries from 2010 to 2017 finds strong evidence for financing, policy and workforce inputs but substantial gaps in social accountability and information systems, underscoring the need for rigorous implementation …
DOI: 10.1136/bmjgh-2019-001551 -
Tailored vs. General COVID-19 prevention for adults with mental disabilities residing in group homes: a randomized controlled effectiveness-implementation trial
Tailored Best Practices for COVID-19 prevention in group homes increased vaccine acceptance among non-White residents but did not improve overall vaccination rates or reduce COVID-19 infections compared with standard guideline dissemination; implementation acceptability, appropr…
DOI: 10.1186/s12889-024-18835-w -
FLAWS OF GLOBAL HEALTH GOVERNANCE AS ILLUSTRATED BY THE COVID-19 VACCINE DISTRIBUTION
A critical narrative review analyzing how flaws in global health governance and the COVAX vaccine distribution contributed to inequitable COVID-19 vaccine access, using Brazil (LMIC) and Canada (HIC) as contrasting case studies and offering policy recommendations.
DOI: 10.22409/rcj.v9i23.54728 -
Recent Trends of Therapeutic Strategies against COVID-19
COVID-19 patent landscape across six major countries shows China as the leading filer, vaccines emerging later while traditional Chinese medicines occupy a prominent early therapeutic niche, with India and the United States following in overall counts.
DOI: 10.2174/26669587-v2-e2206100 -
Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication
Discordant financial conflicts of interest disclosures between ASCO conference abstracts and subsequent publications in industry-sponsored solid tumor oncology trials are common, highlighting inconsistent FCOI reporting across venues and regions.
DOI: 10.7717/peerj.6423 -
Editor and peer reviewer financial conflict of interest policies in public health journals
Editorial and peer reviewer financial conflict of interest policies in public health journals are generally weaker and less transparent than author policies, with limited disclosure forms and few editors’ FCOIs publicly disclosed, prompting calls for stronger, more consistent go…
DOI: 10.1093/eurpub/ckaa183 -
Public companies’ transparency in Ukraine: key regulatory requirements
Public Ukrainian PIEs show low transparency in audited financial statements and CSR disclosures, underscoring the need for EU-aligned reforms in reporting and governance.
DOI: 10.21511/pmf.06(1).2017.01 -
Impact of corporate social responsibility on organization’s financial performance: evidence from Maldives public limited companies
CSR disclosures in Maldives public listed companies, measured with a locally tailored framework, are associated with negative financial performance indicators (ROA, ROE, EPS), driven primarily by diversity and environmental dimensions, casting doubt on CSR’s FP benefits in this …
DOI: 10.1186/s43093-021-00075-8 -
Factors affecting the disclosure level of local government financial statements: Role of audit opinion
Financial independence and intergovernmental revenue significantly influence LKPD disclosure levels in Java island districts/cities (2018–2020), with capital expenditure and legislative size showing no direct effect, while audit opinion moderates the FIR and LS relationships.
DOI: 10.21511/imfi.19(3).2022.24 -
The EBITDA disclosed by companies listed on Brazil stock exchange (B3): locations, types, and occurrence count
Brazilian publicly listed firms in 2021 widely disclosed EBITDA, with Original EBITDA plus conciliation dominating disclosures—especially in the Reference Form and Management Report—while a novel NOTE metric reveals emphasis patterns across reports.
DOI: 10.21680/2176-9036.2025v17n1id38661 -
Audit expectation gap: an empirical analysis
Audit expectation gap persists in Nigeria after the 2016 expanded auditor's report, driven by public misunderstanding of auditors' roles and limited impact of the new reporting model, with recommendations for broader non-financial disclosures and regulatory enhancements.
DOI: 10.1186/s43093-020-00016-x -
Research on the Support of Xiaopeng Automobile’s Financial Strategy for Enterprise Growth
Multi-method analysis links Xiaopeng Automobile's financing, investment, and working-capital decisions to growth, highlighting R&D-driven expansion and rapid sales-channel growth alongside persistent profitability and liquidity challenges that require cost-control and debt-struc…
DOI: 10.70267/icbms.2502.6575 -
Adult involvement in teenage childbearing and STD
A critical policy/opinion piece exposing how major US health insurers and HMOs hold substantial investments in tobacco companies, arguing that such financial ties and for-profit healthcare dynamics may conflict with patient interests and shape health policy and clinical practice.
DOI: 10.1016/S0140-6736(95)92105-2 -
Assessing the impact of transparency in asset recovery on public trust: Evidence from Kazakhstan
Transparency in asset recovery is linked to higher public trust in Kazakhstan’s state institutions, but current disclosure is perceived as insufficient and requires stronger accountability and public communication to realize trust gains.
DOI: 10.21511/ppm.23(3).2025.47 -
The law and problematic marketing by private umbilical cord blood banks
A regulatory/legal analysis of how Canada regulates private umbilical cord blood bank marketing, arguing that claims about future unproven therapies are often misleading, fall outside Health Canada’s typical scope, and should be enforced against by the Competition Bureau to prev…
DOI: 10.1186/s12910-020-00494-2 -
A note on seal watching in the Northeast United States
A survey of Northeast seal-watching programs identifies 29 organizations operating 33 programmes, engaging over 55,000 participants annually, with Maine hosting the most activity and boat-based excursions generating the majority of revenue, while NMFS guidelines have limited dis…
DOI: 10.7557/3.2700 -
Selective Disclosure: Exploring Web-Based Accountability Strategies of Charitable NPOs in Indonesia
Indonesian zakat institutions use their websites to demonstrate high accessibility and engagement, while practicing selective financial disclosure that balances transparency with risk of misinterpretation or criticism.
DOI: 10.12928/jreksa.v12i1.12965